AI-Driven Pathological Subtyping for Pancreatic Cancer: Moving From Promise to Practical Application

Read the full article at: Artificial intelligence (AI) continues to generate excitement across oncology, but its real-world clinical impact remains uneven. In this episode of Exploring AI in Oncology, Dr. Ashish Manne, a Gastrointestinal Medical Oncologist at The Ohio State University Comprehensive Cancer Center, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, shares his American Association for Cancer Research (AACR) presentation on AI-driven pathological subtyping in pancreatic cancer and highlights a critical shift: moving AI from theoretical promise to practical application.

You can listen to AI-Driven Pathological Subtyping for Pancreatic Cancer: Moving From Promise to Practical Application online on Radio and Podcast. Open the player on this page to stream the available audio.

AI-Driven Pathological Subtyping for Pancreatic Cancer: Moving From Promise to Practical Application is an episode from Oncology Data Advisor by Oncology Data Advisor™.

This episode is 00:13:40 long.

This episode was published on May 4, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Oncology Data Advisor when more episodes are available from the podcast feed.